Business Model Analysis of AI Medical Imaging Assisted Diagnosis
-
Most AI medical fields are dominated by startups. For them, although the current environment presents a good opportunity to break through...
AI healthcare has been booming in recent years.
Data from sources like Firestone and Arterial Network show that investment trends in medical technology in recent years have leaned toward blockchain, genetics, and biopharmaceutical innovations.
One question arises: With so many AI healthcare companies and frequent reports of achievements, have they actually made money yet?
Frankly speaking, 'we' are still burning cash!
Why hasn’t revenue been realized at every stage? We need to examine whether the business logic is sound.
It’s important to understand that AI healthcare inherently follows a software-based, asset-light business model. When product accuracy is comparable and hospital procurement standards are met...
1. How Should We Price?
Charge per capita? Annual fees? Sell software?
We’ve tried every approach. Hospitals demand low prices for software procurement—low cost for high returns is fundamental.
Eventually, we bundled our solutions with hardware to justify higher prices. But this turned us into a traditional company, unable to sustain valuations in the billions.
This industry is a marathon, not a sprint. The future is bright, but the path is winding. Without a long-term mindset, many will falter—because you can’t run a marathon with a sprinter’s mentality.
Our company faced this too. After burning cash for five years, investor confidence collapsed, making further funding extremely difficult.
We must recognize the trend—this shift is inevitable. Smart healthcare is policy-driven and supply-side heavy.
China’s healthcare issues lie in supply, not demand. Without solving supply-side problems, the root cause remains unaddressed.
I believe the era of connectivity and empowerment has passed. The current phase is about transactions and validation—a clear path to profitability.
With the growth of commercial insurance and the gradual maturity of service-based healthcare systems, we must seize the opportunities in this five-year transaction and validation period.
After understanding the ecosystem and trends, what strategic goals should AI healthcare entrepreneurs pursue? What business models? And at what pace?
Imaging AI is an interdisciplinary field. Technological and product innovation relies on physician guidance. Similarly, developers and product managers must serve not just radiology and pathology departments but also clinical needs.
Here, physician input is critical—using the right tools to solve the right problems. Serving clinical needs is the ultimate goal, centered around addressing core demands.
Moreover, healthcare is a complex, layered market. The biggest divisions are grassroots (primary care) and upper-tier (specialized care).
The grassroots represent an incremental market needing empowerment. It’s still nascent—those who can support and empower it will thrive.
Upper-tier healthcare is a存量 market with ample opportunities, requiring structural adjustments, especially between commercial and public insurance.
Further细分 your niche. Market stratification will only deepen—specialization clarifies positioning.
For example, how should product loops be designed for common diseases versus complex conditions?
Know whether you serve grassroots or upper-tier markets.
Next is the question of drivers. Whether grassroots or upper-tier, the core drivers are threefold: payers, providers, and enablers.
Current trends show pandemic-driven healthcare消费升级 as pivotal. Providers are physicians and institutions; enablers revolve around them. At the core, these three forces drive progress.
Beyond grassroots and payment models, data is key. In mature grassroots and payment markets, data becomes the linchpin for monetization and value爆发.
2. Data Integration Directly Determines Your Product’s Profitability
Analyzing the 'payment + grassroots' market response: In 2016, I conducted extensive ground推广. Back then, I worked in chronic disease management.
Struggling with monetization, we partnered with telecom smart-home services, bundling offerings with fiber-optic upgrade packages. This unlocked our business model.
Today, 'payment + grassroots' delivers the strongest monetization. Its downside? Weak爆发力—lacking internet scalability. Surprisingly, policy-backed payment models show steady存量 growth and落地 potential.
Cautious healthcare investors favor this model, which aligns well with AI healthcare’s trajectory.
For investors, the downside is smart healthcare’s high barriers. Returns aren’t as visible as in other fields, and policies shift yearly. Without clear业绩锁定,冲动投资 is unlikely. Yet产业机构 favor this space for its strong monetization.
Conversely, 'grassroots + data' combinations excel in落地能力 due to刚性需求.
'Grassroots + data' offers stable monetization, ideal for TOG projects.
Through these models, we must develop clear, phased product strategies. Despite big players’ long-standing presence, no one has claimed the prize yet.
Stay清醒 and persistent—your place awaits.
Some ask: What gaps remain in healthcare entrepreneurship?
Some say: By赛道, none. I disagree. From tech to model innovation, pain points abound—opportunities are ripe.
2020’s market showed pandemic-driven investor focus on healthcare.
For healthcare entrepreneurs, weathering the storm may reveal this year’s best opportunities.